The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses
Open accessAbstract
Summary: Tuberculosis (TB) lesions are extremely complex and dynamic. Here, we review the multiple types and fates of pulmonary lesions that form following infection by M ycobacterium tuberculosis and the impact of this spatial and temporal heterogeneity on the bacteria they harbor. The diverse immunopathology of granulomas and cavities generates a plethora of microenvironments to which M. tuberculosis bacilli must adapt. This in turn affects the replication, metabolism, and relative density of bacterial subpopulations, and consequently their respective susceptibility to chemotherapy. We outline recent developments that support a paradigm shift in our understanding of lesion progression. The simple model according to which lesions within a single individual react similarly to the systemic immune response no longer prevails. Host‐pathogen interactions within lesions are a dynamic process, driven by subtle and local differences in signaling pathways, resulting in diverging trajectories of lesions within a single host. The spectrum of TB lesions is a continuum with a large overlap in the lesion types found in latently infected and active TB patients. We hope this overview will guide TB researchers in the design, choice of read‐outs, and interpretation of future studies in the search for predictive biomarkers and novel therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
Barry, C. E., Boshoff, H. I., Dartois, V., Dick, T., Ehrt, S., Flynn, J., Schnappinger, D., Wilkinson, R. J., & Young, D. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2236 · Cited by 1,422
Self-citationTranscriptional Adaptation of Mycobacterium tuberculosis within Macrophages
Schnappinger, D., Ehrt, S., Voskuil, M. I., Liu, Y., Mangan, J. A., Monahan, I. M., Dolganov, G., Efron, B., Butcher, P. D., Nathan, C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030846 · Cited by 1,420
McKinney, J. D., zu Bentrup, K. H., Muñoz-Elías, E. J., Miczak, A., Chen, B., Chan, W.-T., Swenson, D., Sacchettini, J. C., Jacobs, W. R., & Russell, D. G. (2000) · Nature · doi:10.1038/35021074 · Cited by 1,360
Wayne, L. G., & Hayes, L. G. (1996) · Infection and Immunity · doi:10.1128/iai.64.6.2062-2069.1996 · Cited by 1,141
Mycobacterial persistence requires the utilization of host cholesterol
Pandey, A. K., & Sassetti, C. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711159105 · Cited by 1,064
Inhibition of Respiration by Nitric Oxide Induces a Mycobacterium tuberculosis Dormancy Program
Voskuil, M. I., Schnappinger, D., Visconti, K. C., Harrell, M. I., Dolganov, G. M., Sherman, D. R., & Schoolnik, G. K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030205 · Cited by 966
Nonreplicating Persistence of Mycobacterium Tuberculosis
Wayne, L. G., & Sohaskey, C. D. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.139 · Cited by 807
Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review
Steingart, K. R., Henry, M., Ng, V., Hopewell, P. C., Ramsay, A., Cunningham, J., Urbanczik, R., Perkins, M., Aziz, M. A., & Pai, M. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70578-3 · Cited by 798
Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
Mayer-Barber, K. D., Andrade, B. B., Oland, S. D., Amaral, E. P., Barber, D. L., Gonzales, J., Derrick, S. C., Shi, R., Kumar, N. P., Wei, W., et al. (2014) · Nature · doi:10.1038/nature13489 · Cited by 767
A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response
Reed, M. B., Domenech, P., Manca, C., Su, H., Barczak, A. K., Kreiswirth, B. N., Kaplan, G., & Barry, C. E. (2004) · Nature · doi:10.1038/nature02837 · Cited by 762
Self-citationMuñoz-Elías, E. J., & McKinney, J. D. (2005) · Nature Medicine · doi:10.1038/nm1252 · Cited by 756
Fox, W., Ellard, G. A., & MITCHISON, D. A. (1999) · PubMed · Cited by 676
Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates
Via, L. E., Lin, P. L., Ray, S. M., Carrillo, J., Allen, S. S., Eum, S. Y., Taylor, K., Klein, E., Manjunatha, U., Gonzales, J., et al. (2008) · Infection and Immunity · doi:10.1128/iai.01515-07 · Cited by 664
Self-citationDaniel, J., Maamar, H., Deb, C., Sirakova, T. D., & Kolattukudy, P. E. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002093 · Cited by 608
Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
Tobin, D. M., Roca, F. J., Oh, S. F., McFarland, R., Vickery, T. W., Ray, J. P., Ko, D. C., Zou, Y., Bang, N. D., Chau, T. T. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.023 · Cited by 580
The immunological life cycle of tuberculosis
Ernst, J. D. (2012) · Nature Reviews Immunology · doi:10.1038/nri3259 · Cited by 577
Phagosomal Rupture by Mycobacterium tuberculosis Results in Toxicity and Host Cell Death
Simeone, R., Bobard, A., Lippmann, J., Bitter, W., Majlessi, L., Brosch, R., & Enninga, J. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002507 · Cited by 561
Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis
Lee, M., Lee, J., Carroll, M. W., Choi, H., Min, S., Song, T., Via, L. E., Goldfeder, L. C., Kang, E., Jin, B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201964 · Cited by 560
Self-citationAnti-inflammatory therapies for cardiovascular disease
Ridker, P. M., & Luscher, T. F. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu203 · Cited by 550
Eum, S.-Y., Kong, J.-H., Hong, M.-S., Lee, Y.-J., Kim, J.-H., Hwang, S.-H., Cho, S.-N., Via, L. E., & Barry, C. E. (2010) · Chest · doi:10.1378/chest.09-0903 · Cited by 548
Self-citationMechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis
Vergne, I., Chua, J., Lee, H.-H., Lucas, M., Belisle, J., & Deretic, V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409716102 · Cited by 541
Lin, P. L., Ford, C. B., Coleman, M. T., Myers, A. J., Gawande, R., Ioerger, T., Sacchettini, J., Fortune, S. M., & Flynn, J. L. (2014) · Nature Medicine · doi:10.1038/nm.3412 · Cited by 533
The lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans
Tobin, D. M., Vary, J. C., Ray, J. P., Walsh, G. S., Dunstan, S. J., Bang, N. D., Hagge, D. A., Khadge, S., King, M.-C., Hawn, T. R., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.013 · Cited by 528
The action of antituberculosis drugs in short-course chemotherapy
Mitchison, D. A. (1985) · Tubercle · doi:10.1016/0041-3879(85)90040-6 · Cited by 518
Serruys, P. W., García-García, H. M., Buszman, P., Erne, P., Verheye, S., Aschermann, M., Duckers, H., Bleie, O., Dudek, D., Bøtker, H. E., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.771899 · Cited by 505
Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism
Kim, M., Wainwright, H. C., Locketz, M., Bekker, L., Walther, G. B., Dittrich, C., Visser, A., Wang, W., Hsu, F., Wiehart, U., et al. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000079 · Cited by 489
Capuano, S. V., Croix, D. A., Pawar, S., Zinovik, A., Myers, A., Lin, P. L., Bissel, S., Fuhrman, C., Klein, E., & Flynn, J. L. (2003) · Infection and Immunity · doi:10.1128/iai.71.10.5831-5844.2003 · Cited by 479
Deb, C., Lee, C.-M., Dubey, V. S., Daniel, J., Abomoelak, B., Sirakova, T. D., Pawar, S., Rogers, L., & Kolattukudy, P. E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006077 · Cited by 440
Evasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?
Behar, S. M., Divangahi, M., & Remold, H. G. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2387 · Cited by 435
Cytological and Transcript Analyses Reveal Fat and Lazy Persister-Like Bacilli in Tuberculous Sputum
Garton, N. J., Waddell, S. J., Sherratt, A. L., Lee, S.-M., Smith, R. J., Senner, C., Hinds, J., Rajakumar, K., Adegbola, R. A., Besra, G. S., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050075 · Cited by 435
The Mycobacterium tuberculosis regulatory network and hypoxia
Galagan, J. E., Minch, K., Peterson, M., Lyubetskaya, A., Azizi, E., Sweet, L., Gomes, A., Rustad, T., Dolganov, G., Glotova, I., et al. (2013) · Nature · doi:10.1038/nature12337 · Cited by 431
Tsuda, Y., Takahashi, H., Kobayashi, M., Hanafusa, T., Herndon, D. N., & Suzuki, F. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.006 · Cited by 425
Quantitative Comparison of Active and Latent Tuberculosis in the Cynomolgus Macaque Model
Lin, P. L., Rodgers, M., Smith, L., Bigbee, M., Myers, A., Bigbee, C., Chiosea, I., Capuano, S. V., Fuhrman, C., Klein, E., et al. (2009) · Infection and Immunity · doi:10.1128/iai.00592-09 · Cited by 425
New insights into the function of granulomas in human tuberculosis
Ulrichs, T., & Kaufmann, S. H. (2006) · The Journal of Pathology · doi:10.1002/path.1906 · Cited by 416
Tsai, M. C., Chakravarty, S., Zhu, G., Xu, J., Tanaka, K., Koch, C., Tufariello, J., Flynn, J., & Chan, J. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00612.x · Cited by 414
Neutrophil-mediated innate immune resistance to mycobacteria
Martineau, A. R., Newton, S. M., Wilkinson, K. A., Kampmann, B., Hall, B. M., Nawroly, N., Packe, G. E., Davidson, R. N., Griffiths, C. J., & Wilkinson, R. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31097 · Cited by 394
Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection
Nandi, B., & Behar, S. M. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110919 · Cited by 374
The temporal expression profile of Mycobacterium tuberculosis infection in mice
Talaat, A. M., Lyons, R., Howard, S. T., & Johnston, S. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306023101 · Cited by 363
Mycobacterium tuberculosis Growth at theCavity Surface: a Microenvironment with FailedImmunity
Kaplan, G., Post, F. A., Moreira, A. L., Wainwright, H., Kreiswirth, B. N., Tanverdi, M., Mathema, B., Ramaswamy, S. V., Walther, G., Steyn, L. M., et al. (2003) · Infection and Immunity · doi:10.1128/iai.71.12.7099-7108.2003 · Cited by 350
Self-citationMarrero, J., Rhee, K. Y., Schnappinger, D., Pethe, K., & Ehrt, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000715107 · Cited by 347
Mattila, J. T., Ojo, O. O., Kepka-Lenhart, D., Marino, S., Kim, J. H., Eum, S. Y., Via, L. E., Barry, C. E., Klein, E., Kirschner, D. E., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300113 · Cited by 347
Self-citationReduction of Clofazimine by Mycobacterial Type 2 NADH:Quinone Oxidoreductase
Yano, T., Kassovska-Bratinova, S., Teh, J. S., Winkler, J., Sullivan, K., Isaacs, A., Schechter, N. M., & Rubin, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.200501 · Cited by 346
Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis
Kramnik, I., Dietrich, W. F., Demant, P., & Bloom, B. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150227197 · Cited by 345
Swaim, L. E., Connolly, L. E., Volkman, H. E., Humbert, O., Born, D. E., & Ramakrishnan, L. (2006) · Infection and Immunity · doi:10.1128/iai.00887-06 · Cited by 328
The ongoing challenge of latent tuberculosis
Esmail, H., Barry, C. E., Young, D. B., & Wilkinson, R. J. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0437 · Cited by 325
Self-citationNeutrophils in tuberculosis: friend or foe?
Lowe, D. M., Redford, P. S., Wilkinson, R. J., O’Garra, A., & Martineau, A. R. (2012) · Trends in Immunology · doi:10.1016/j.it.2011.10.003 · Cited by 312
Bloom, C. I., Graham, C. M., Berry, M. P. R., Rozakeas, F., Redford, P. S., Wang, Y., Xu, Z., Wilkinson, K. A., Wilkinson, R. J., Kendrick, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070630 · Cited by 304
Mass spectrometry imaging for drug distribution studies
Prideaux, B., & Stoeckli, M. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.07.028 · Cited by 279
Deb, C., Daniel, J., Sirakova, T. D., Abomoelak, B., Dubey, V. S., & Kolattukudy, P. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m505556200 · Cited by 276
Driver, E. R., Ryan, G. J., Hoff, D. R., Irwin, S. M., Basaraba, R. J., Kramnik, I., & Lenaerts, A. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00217-12 · Cited by 266
Self-citationPrideaux, B., Dartois, V., Staab, D., Weiner, D. M., Goh, A., Via, L. E., Barry, C. E., & Stoeckli, M. (2011) · Analytical Chemistry · doi:10.1021/ac1029049 · Cited by 260
Self-citationLocation of Persisting Mycobacteria in a Guinea Pig Model of Tuberculosis Revealed by R207910
Lenaerts, A. J., Hoff, D., Aly, S., Ehlers, S., Andries, K., Cantarero, L., Orme, I. M., & Basaraba, R. J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00276-07 · Cited by 257
Self-citationMouse Model of Necrotic Tuberculosis Granulomas Develops Hypoxic Lesions
Harper, J., Skerry, C., Davis, S. L., Tasneen, R., Weir, M., Kramnik, I., Bishai, W. R., Pomper, M. G., Nuermberger, E. L., & Jain, S. K. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir786 · Cited by 256
Fumarate Reductase Activity Maintains an Energized Membrane in Anaerobic Mycobacterium tuberculosis
Watanabe, S., Zimmermann, M., Goodwin, M. B., Sauer, U., Barry, C. E., & Boshoff, H. I. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002287 · Cited by 246
Self-citationLin, P. L., Myers, A., Smith, L., Bigbee, C., Bigbee, M., Fuhrman, C., Grieser, H., Chiosea, I., Voitenek, N. N., Capuano, S. V., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27271 · Cited by 244
Raleigh, J. A., Calkins-Adams, D. P., Rinker, L. H., Ballenger, C. A., Weissler, M. C., Fowler, W. C., Novotny, D. B., & Varia, M. A. (1998) · PubMed · Cited by 241
Early Events in Mycobacterium tuberculosis Infection in Cynomolgus Macaques
Lin, P. L., Pawar, S., Myers, A., Pegu, A., Fuhrman, C., Reinhart, T. A., Capuano, S. V., Klein, E., & Flynn, J. L. (2006) · Infection and Immunity · doi:10.1128/iai.00064-06 · Cited by 233
Replication Dynamics of Mycobacterium tuberculosis in Chronically Infected Mice
Muñoz-Elías, E. J., Timm, J., Botha, T., Chan, W.-T., Gomez, J. E., & McKinney, J. D. (2005) · Infection and Immunity · doi:10.1128/iai.73.1.546-551.2005 · Cited by 226
Vilaplana, C., Marzo, E., Tapia, G., Diaz, J., Garcia, V., & Cardona, P.-J. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit152 · Cited by 220
Eliminating latent tuberculosis
Young, D. B., Gideon, H. P., & Wilkinson, R. J. (2009) · Trends in Microbiology · doi:10.1016/j.tim.2009.02.005 · Cited by 220
Langermans, J. A. M., Andersen, P., van Soolingen, D., Vervenne, R. A. W., Frost, P. A., van der Laan, T., van Pinxteren, L. A. H., van den Hombergh, J., Kroon, S., Peekel, I., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201404898 · Cited by 204
Bhatt, A., Fujiwara, N., Bhatt, K., Gurcha, S. S., Kremer, L., Chen, B., Chan, J., Porcelli, S. A., Kobayashi, K., Besra, G. S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608654104 · Cited by 202
Tailleux, L., Waddell, S. J., Pelizzola, M., Mortellaro, A., Withers, M., Tanne, A., Castagnoli, P. R., Gicquel, B., Stoker, N. G., Butcher, P. D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001403 · Cited by 195
Local Immune Responses Correlate with Presentation and Outcome in Tuberculosis
CONDOS, R., ROM, W. N., LIU, Y. M., & SCHLUGER, N. W. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.9705044 · Cited by 195
Oxygen status of lung granulomas in Mycobacterium tuberculosis‐infected mice
Aly, S., Wagner, K., Keller, C., Malm, S., Malzan, A., Brandau, S., Bange, F., & Ehlers, S. (2006) · The Journal of Pathology · doi:10.1002/path.2055 · Cited by 185
Radiologic Responses in Cynomolgus Macaques for Assessing Tuberculosis Chemotherapy Regimens
Lin, P. L., Coleman, T., Carney, J. P. J., Lopresti, B. J., Tomko, J., Fillmore, D., Dartois, V., Scanga, C., Frye, L. J., Janssen, C., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00277-13 · Cited by 184
Self-citationYuan, Y., Zhu, Y., Crane, D. D., & Barry III, C. E. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.01026.x · Cited by 176
The non‐human primate model of tuberculosis
Kaushal, D., Mehra, S., Didier, P. J., & Lackner, A. A. (2012) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.2012.00536.x · Cited by 166
Pharmacokinetic Evaluation of the Penetration of Antituberculosis Agents in Rabbit Pulmonary Lesions
Kjellsson, M. C., Via, L. E., Goh, A., Weiner, D., Low, K. M., Kern, S., Pillai, G., Barry, C. E., & Dartois, V. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05208-11 · Cited by 164
Self-citationManabe, Y. C., Dannenberg, A. M., Tyagi, S. K., Hatem, C. L., Yoder, M., Woolwine, S. C., Zook, B. C., Pitt, M. L. M., & Bishai, W. R. (2003) · Infection and Immunity · doi:10.1128/iai.71.10.6004-6011.2003 · Cited by 163
Cell‐Wall Alterations as an Attribute of Mycobacterium tuberculosis in Latent Infection
Seiler, P., Ulrichs, T., Bandermann, S., Pradl, L., Jörg, S., Krenn, V., Morawietz, L., Kaufmann, S. H. E., & Aichele, P. (2003) · The Journal of Infectious Diseases · doi:10.1086/378563 · Cited by 157 · cited 1×
“The acid-fastness of mycobacteria in mice reduces significantly over time (65).”
BackgroundCorleis, B., Korbel, D., Wilson, R., Bylund, J., Chee, R., & Schaible, U. E. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01783.x · Cited by 150
Rosenthal, I. M., Tasneen, R., Peloquin, C. A., Zhang, M., Almeida, D. V., Mdluli, K. E., Karakousis, P. C., Grosset, J. H. E., & Nuermberger, E. L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00912-12 · Cited by 148
A new unifying theory of the pathogenesis of tuberculosis
Orme, I. M. (2013) · Tuberculosis · doi:10.1016/j.tube.2013.07.004 · Cited by 147
Weber, I., Fritz, C., Ruttkowski, S., Kreft, A., & Bange, F. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01794.x · Cited by 144
Coleman, M. T., Chen, R. Y., Lee, M., Lin, P. L., Dodd, L. E., Maiello, P. A., Via, L. E., Kim, Y., Marriner, G. A., Dartois, V. A., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009500 · Cited by 142
Self-citationGranuloma Encapsulation Is a Key Factor for Containing Tuberculosis Infection in Minipigs
Gil, O., Díaz, I., Vilaplana, C., Tapia, G., Díaz, J., Fort, M., Cáceres, N., Pinto, S., Caylà, J. A., Corner, L. A. L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010030 · Cited by 137
A Nested Case–Control Study on Treatment-related Risk Factors for Early Relapse of Tuberculosis
Chang, K. C., Leung, C. C., Yew, W. W., Ho, S. C., & Tam, C. M. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-905oc · Cited by 137
Davis, S. L., Nuermberger, E. L., Um, P. K., Vidal, C., Jedynak, B., Pomper, M. G., Bishai, W. R., & Jain, S. K. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00789-09 · Cited by 134
Damaging role of neutrophilic infiltration in a mouse model of progressive tuberculosis
Marzo, E., Vilaplana, C., Tapia, G., Díaz, J., Garcia, V. V., & Cardona, P.-J. (2013) · Tuberculosis · doi:10.1016/j.tube.2013.09.004 · Cited by 132
Neutrophilia independently predicts death in tuberculosis
Lowe, D. M., Bandara, A. K., Packe, G. E., Barker, R. D., Wilkinson, R. J., Griffiths, C., & Martineau, A. R. (2013) · European Respiratory Journal · doi:10.1183/09031936.00140913 · Cited by 131
Basaraba, R. J. (2008) · Tuberculosis · doi:10.1016/s1472-9792(08)70035-0 · Cited by 128
Sharpe, S. A., McShane, H., Dennis, M. J., Basaraba, R. J., Gleeson, F. V., Hall, G. A., McIntyre, A., Gooch, K. E., Clark, S. O., Beveridge, N. E. R., et al. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00079-10 · Cited by 127
Via, L. E., Weiner, D. M., Schimel, D. M., Lin, P. L., Dayao, E. K., Tankersley, S. L., Cai, Y., Coleman, M. T., Tomko, J. A., Paripati, P., et al. (2013) · Infection and Immunity · doi:10.1128/iai.00632-13 · Cited by 126
Self-citationBrandli, I., Papadopoulos, A., Malaga, W., Marais, D. A., Canaan, S., Thilo, L., & de Chastellier, C. (2013) · Infection and Immunity · doi:10.1128/iai.01196-13 · Cited by 125
Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques
Lin, P. L., Dartois, V. A., Johnston, P. J., Janssen, C., Via, L. E., Goodwin, M. B., Klein, E. C., Barry, C. E., & Flynn, J. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121497109 · Cited by 123
Self-citationIrwin, S. M., Gruppo, V., Brooks, E. J., Gilliland, J. C., Scherman, M., Reichlen, M. J., Leistikow, R. L., Kramnik, I., Nuermberger, E. L., Voskuil, M. I., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02565-14 · Cited by 122
Self-citationChronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response
Subbian, S., Tsenova, L., Yang, G., O’Brien, P. E., Parsons, S. D. C., Peixoto, B., Taylor, L., Fallows, D. A., & Kaplan, G. (2011) · Open Biology · doi:10.1098/rsob.110016 · Cited by 120
Simvastatin increases the in vivo activity of the first-line tuberculosis regimen
Skerry, C. M., Pinn, M. L., Bruiners, N., Pine, R. I., Gennaro, M. L., & Karakousis, P. C. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku166 · Cited by 119
Via, L. E., Schimel, D., Weiner, D. M., Dartois, V. A., Dayao, E. K., Cai, Y., Yoon, Y.-S., Dreher, M. R., Kastenmayer, R. J., Laymon, C. M., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00531-12 · Cited by 114
Self-citationThe aerosol rabbit model of TB latency, reactivation and immune reconstitution inflammatory syndrome
Manabe, Y. C., Kesavan, A. K., Lopez-Molina, J., Hatem, C. L., Brooks, M. E., Fujiwara, R. T., Hochstein, K., Pitt, M. L. M., Tufariello, J. M., Chan, J., et al. (2007) · Tuberculosis · doi:10.1016/j.tube.2007.10.006 · Cited by 114
Ulrichs, T., Lefmann, M., Reich, M., Morawietz, L., Roth, A., Brinkmann, V., Kosmiadi, G., Seiler, P., Aichele, P., Hahn, H., et al. (2005) · Journal of Pathology · doi:10.1002/path.1728 · Cited by 110
Pathogenesis of Human Pulmonary Tuberculosis
Dannenberg, A. M. (2006) · ASM Press eBooks · doi:10.1128/9781555815684 · Cited by 108
Fritz, C., Maass, S., Kreft, A., & Bange, F. (2002) · Infection and Immunity · doi:10.1128/iai.70.1.286-291.2002 · Cited by 103
How Mycobacterium Tuberculosis goes to Sleep: The Dormancy Survival Regulator DosR a Decade Later
Boon, C., & Dick, T. (2012) · Future Microbiology · doi:10.2217/fmb.12.14 · Cited by 101
Cutting Edge: Vitamin D Regulates Lipid Metabolism in Mycobacterium tuberculosis Infection
Salamon, H., Bruiners, N., Lakehal, K., Shi, L., Ravi, J., Yamaguchi, K. D., Pine, R., & Gennaro, M. L. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400736 · Cited by 99
Palanisamy, G. S., Smith, E. E., Shanley, C. A., et al. (2008) · Tuberculosis · doi:10.1016/j.tube.2007.12.003 · Cited by 95
Cappelli, G., Volpe, E., Grassi, M., Liseo, B., Colizzi, V., & Mariani, F. (2006) · Research in Microbiology · doi:10.1016/j.resmic.2005.10.007 · Cited by 94
Darrah, P. A., Bolton, D. L., Lackner, A. A., Kaushal, D., Aye, P. P., Mehra, S., Blanchard, J., Didier, P. J., Roy, C. J., Rao, S. S., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400676 · Cited by 91
Changing Concepts of “Latent Tuberculosis Infection” in Patients Living with HIV Infection
Lawn, S. D., Wood, R., & Wilkinson, R. J. (2010) · Clinical and Developmental Immunology · doi:10.1155/2011/980594 · Cited by 90
Efficacy and Safety of Metronidazole for Pulmonary Multidrug-Resistant Tuberculosis
Carroll, M. W., Jeon, D., Mountz, J. M., Lee, J. D., Jeong, Y. J., Zia, N., Lee, M., Lee, J., Via, L. E., Lee, S., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00753-13 · Cited by 90
Self-citationSubbian, S., Tsenova, L., O’Brien, P. E., Yang, G., Koo, M.-S., Peixoto, B., Fallows, D. A., Zeldis, J. B., Muller, G. W., & Kaplan, G. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.039 · Cited by 89
Subbian, S., Bandyopadhyay, N., Tsenova, L., O’Brien, P. E., Khetani, V., Kushner, N. L., Peixoto, B., Soteropoulos, P., Bader, J. S., Karakousis, P. C., et al. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-60 · Cited by 85
Predictors of Short-Term Prognosis in Patients with Pulmonary Tuberculosis
Barnes, P. F., Leedom, J. M., Chan, L. S., Wong, S. F., Shah, J. J., Vachon, L. A., Overturf, G. D., & Modlin, R. L. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/158.2.366 · Cited by 83
Ryan, G. J., Hoff, D. R., Driver, E., Voskuil, M. I., Juarrero, M. G., Basaraba, R. J., Crick, D. C., Spencer, J. S., & Lenaerts, A. J. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011108 · Cited by 80
Self-citationBaik, J., Stringer, K. A., Mane, G., & Rosania, G. R. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01731-12 · Cited by 79
A Color Atlas of Comparative Pathology of Pulmonary Tuberculosis
(2010) · CRC Press eBooks · doi:10.1201/ebk1439835272 · Cited by 76
Whole Blood Bactericidal Activity during Treatment of Pulmonary Tuberculosis
Wallis, R. S., Vinhas, S. A., Johnson, J. L., Ribeiro, F. C., Palaci, M., Peres, R. L., Sá, R. T., Dietze, R., Chiunda, A. B., Eisenach, K. D., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/346053 · Cited by 76
Spontaneous Latency in a Rabbit Model of Pulmonary Tuberculosis
Subbian, S., Tsenova, L., O’Brien, P. E., Yang, G., Kushner, N. L., Parsons, S. D. C., Peixoto, B., Fallows, D. A., & Kaplan, G. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.07.019 · Cited by 75
Gr1intCD11b+ Myeloid-Derived Suppressor Cells in Mycobacterium tuberculosis Infection
Obregón-Henao, A., Henao-Tamayo, M., Orme, I. M., & Ordway, D. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080669 · Cited by 74
Skerry, C. M., Harper, J. S., Klunk, M. H., Bishai, W. R., & Jain, S. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039680 · Cited by 74
Looking Within the Zebrafish to Understand the Tuberculous Granuloma
Ramakrishnan, L. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-6111-1_13 · Cited by 73
Lipid lunch for persistent pathogen
Bishai, W. R. (2000) · Nature · doi:10.1038/35021159 · Cited by 66
Aber, V. R., & Nunn, A. (1978) · PubMed · Cited by 65
Gene expression profiles of bronchoalveolar cells in pulmonary TB
Raju, B., Hoshino, Y., Belitskaya‐Lévy, I., Dawson, R., Ress, S., Gold, J. A., Condos, R., Pine, R. I., Brown, S. M., Nolan, A., et al. (2007) · Tuberculosis · doi:10.1016/j.tube.2007.07.003 · Cited by 63
TB: the Yin and Yang of lipid mediators
Tobin, D. M., & Ramakrishnan, L. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.06.007 · Cited by 57
Metronidazole has no antibacterial effect in Cornell model murine tuberculosis.
Dhillon, J., Allen, B. W., Hu, Y., Coates, A. R. M., & Mitchison, D. A. (1998) · PubMed · Cited by 57
Ryan, G. J., Shapiro, H. M., & Lenaerts, A. J. M. (2014) · Tuberculosis · doi:10.1016/j.tube.2014.07.004 · Cited by 55
Self-citationSánchez, J., Tomas, L. G., Ortega, N., Buendía, A. J., Rı́o, L. D., Salinas, J., Bezos, J., Caro, M. R., & Navarro, J. A. (2011) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2010.12.006 · Cited by 44
Watching intracellular lipolysis in mycobacteria using time lapse fluorescence microscopy
Dhouib, R., Ducret, A., Hubert, P., Carrière, F., Dukan, S., & Canaan, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.01.001 · Cited by 43
Aly, S., Laskay, T., Mages, J., Malzan, A., Lang, R., & Ehlers, S. (2007) · The Journal of Pathology · doi:10.1002/path.2185 · Cited by 42
Metronidazole Lacks Antibacterial Activity in Guinea Pigs Infected with Mycobacterium tuberculosis
Hoff, D. R., Caraway, M. L., Brooks, E. J., Driver, E., Ryan, G. J., Peloquin, C. A., Orme, I. M., Basaraba, R. J., & Lenaerts, A. J. M. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00196-08 · Cited by 40
Self-citationBağcı, U., Foster, B. H., Miller-Jaster, K., Luna, B. M., Dey, B., Bishai, W. R., Jonsson, C. B., Jain, S. K., & Mollura, D. J. (2013) · EJNMMI Research · doi:10.1186/2191-219x-3-55 · Cited by 37
Mitchison, D. A. (1959) · BMJ · doi:10.1136/bmj.1.5122.631-b · Cited by 29
Experimental aerosol Mycobacterium bovis model of infection in goats
Juarrero, M. G., Bosco‐Lauth, A. M., Podell, B. K., Soffler, C., Brooks, E. J., Izzo, A. A., Sánchez-Campillo, J., & Bowen, R. (2013) · Tuberculosis · doi:10.1016/j.tube.2013.05.006 · Cited by 29
Imaging the Evolution of Reactivation Pulmonary Tuberculosis in Mice Using 18F-FDG PET
Murawski, A. M., Gurbani, S. S., Harper, J. S., Klunk, M. H., Laurent Younes, B., Jain, S. K., & Jedynak, B. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.144634 · Cited by 25
Molecular genetic characterisation of a mycobacterial homologue of a sporulation factor
Hutter, B., & Dick, T. (1999) · Research in Microbiology · doi:10.1016/s0923-2508(99)80055-2 · Cited by 20
Darapladib: an emerging therapy for atherosclerosis
Corson, M. A. (2010) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944710375820 · Cited by 20
BCG Induces Protection against Mycobacterium tuberculosis Infection in the Wistar Rat Model
Singhal, A., Mathys, V., Kiass, M., Creusy, C., Delaire, B., Aliouat, E. M., Dartois, V. A., Kaplan, G., & Bifani, P. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028082 · Cited by 17
Self-citationInnate Immunity to TB: A Druggable Balancing Act
Lalvani, A., Behr, M. A., & Sridhar, S. (2012) · Cell · doi:10.1016/j.cell.2012.01.026 · Cited by 13
Cited by
Host-directed therapies for bacterial and viral infections
Kaufmann, S. H. E., Dorhoi, A., Hotchkiss, R. S., & Bartenschlager, R. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.162 · Cited by 831
Drain, P. K., Bajema, K. L., Dowdy, D., Dheda, K., Naidoo, K., Schumacher, S. G., Ma, S., Meermeier, E., Lewinsohn, D. M., & Sherman, D. R. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00021-18 · Cited by 565
Extra Pulmonary Tuberculosis: An Overview
J. Cantres-Fonseca, O., Rodriguez-Cintrón, W., Del Olmo-Arroyo, F., & Baez-Corujo, S. (2019) · Role of Microbes in Human Health and Diseases · doi:10.5772/intechopen.81322 · Cited by 514
Anti-tuberculosis treatment strategies and drug development: challenges and priorities
Dartois, V. A., & Rubin, E. J. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00731-y · Cited by 490
Self-citationCadena, A. M., Fortune, S. M., & Flynn, J. L. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.69 · Cited by 484
Metadata
- Authors
- Lenaerts, A., Barry, C. E., & Dartois, V.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2015-02-20
- Volume
- 264
- Issue
- 1
- Pages
- 288-307
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2142356297
- Cited by
- 362
- References
- 133
- FWCI
- 6.60
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.